Pallidopyramidal disease: A misnomer?

Movement Disorders

Volumn 25, Issue 9, 2010, Pages 1109-1115

  Horstink, Martin W I M ^a   Dekker, Marieke C ^a   Montagna, Pasquale ^b   Bonifati, Vincenzo ^c   Van De Warrenburg, Bart P ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Juvenile parkinsonism; Pallidal atrophy; Pallidopyramidal; Pseudobabinski; Pyramidal syndrome

Indexed keywords

BABINSKI REFLEX; DISEASE CLASSIFICATION; DYSTONIA; HISTORY OF MEDICINE; HUMAN; NERVE DEGENERATION; NOMENCLATURE; PARKINSONISM; PRIORITY JOURNAL; PYRAMIDAL SIGN; REVIEW; SHY DRAGER SYNDROME; WILSON DISEASE; DEGENERATIVE DISEASE; FEMALE; GLOBUS PALLIDUS; HISTORY; MALE; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PYRAMIDAL TRACT;

FEMALE; GLOBUS PALLIDUS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MALE; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PYRAMIDAL TRACTS;

EID: 77955060548     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23118     Document Type: Review

References (68)

1. Davison C. Pallido-pyramidal disease. J Neuropathol Exp Neurol 1954;13:50-59.
2. Ramsay Hunt J. Progressive atrophy of the globus pallidus (primary atrophy of the pallidal system). Brain 1917;40:59-148.
3. Keppel Hesselink JM. Evolution of concepts and definitions of Parkinson's disease since 1817. J Hist Neurosci 1996;5:200-207.
4. Williams DR, Hadeed A, Al-Din AS, Wreikat AL, Lees AJ. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov Disord 2005;20:1264-1271. (Pubitemid 41645900)
5. Horowitz G, Greenberg J. Pallido-pyramidal syndrome treated with levodopa. J Neurol Neurosurg Psychiatry 1975;38:238-240.
6. Kalita J, Misra UK, Das BK. Sporadic variety of pallido-pyramidal syndrome. Neurol India 2003;51:383-384.
7. Panagariya A, Sharma B, Dev A. Pallido-pyramidal syndrome: a rare entity. Indian J Med Sci 2007;61:156-157.
8. Pradat PF, Dupel-Pottier C, Lacomblez L, et al. Case report of pallido-pyramidal disease with supplementary motor area involvement. Mov Disord 2001;16:762-764. (Pubitemid 36040863)
9. Remy P, Hosseini H, Degos JD, et al. Striatal dopaminergic denervation in pallidopyramidal disease demonstrated by positron emission tomography. Ann Neurol 1995;38:954-956. (Pubitemid 26004078)
10. Srivastava T, Goyal V, Singh S, Shukla G, Behari M. Pallidopyramidal syndrome with blepharospasm and good response to levodopa. J Neurol 2005;252:1537-1538. (Pubitemid 41803846)
11. Tranchant C, Boulay C, Warter JM. [Pallido-pyramidal syndrome: an unrecognized entity]. Rev Neurol (Paris) 1991;147: 308-310.
12. Nisipeanu P, Kuritzky A, Korczyn AD. Familial levodopa-responsive parkinsonian-pyramidal syndrome. Mov Disord 1994;9: 673-675.
13. Rajendran P, Aleem MA, Chandrasekaran R, Raveendran S, Ramasubramanian D. Familial Parkinsonian pyramidal syndrome. Neurol India 2000;48:297-298.
14. Horstink MW, Haaxma C, Bloem BR, Duysens J. Babinski, pseudo-Babinski, and dystonia. Arch Neurol 2007;64:1207-1209.
15. Nausieda PA, Weiner WJ, Klawans HL. Dystonic foot response of Parkinsonism. Arch Neurol 1980;37:132-136.
16. Winkler AS, Reuter I, Harwood G, Chaudhuri KR. The frequency and significance of 'striatal toe' in parkinsonism. Parkinsonism Relat Disord 2002;9:97-101.
17. Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson's disease. Lancet Neurol 2005;4:423-431. (Pubitemid 40826533)
18. Jan MM. Misdiagnoses in children with dopa-responsive dystonia. Pediatr Neurol 2004;31:298-303.
19. Nygaard TG, Waran SP, Levine RA, Naini AB, Chutorian AM. Dopa-responsive dystonia simulating cerebral palsy. Pediatr Neurol 1994;11:236-240.
20. Twitchell TE. On the motor deficit in congenital bilateral athetosis. J Nerv Ment Dis 1959;129:105-132.
21. Tassin J, Durr A, Bonnet AM, et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain 2000;123: 1112-1121.
22. Quinn N, Daniel S, Magalhaes-Branco M, Lees A, Hughes A. Lack of pyramidal tract signs in Parkinson's disease. Lancet 1992;340:125.
23. Vogt C. Quelques considérations générales a propos du syndrome du corps strié. J Psychol Neurol Lpz 1911;18:479-488.
24. Freund CS, Vogt C. Ein neuer fall von Etat marbré des corpus striatum. J Psychol Neurol Lpz 1911;18:489-499.
25. Jellinger K. [Progressive pallidal atrophy]. J Neurol Sci 1968;6: 19-44.
26. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 2003;54:176-185.
27. Jankovic J, Tintner R. Dystonia and parkinsonism. Parkinsonism Relat Disord 2001;8:109-121.
28. Muthane UB, Swamy HS, Satishchandra P, Subhash MN, Rao S, Subbakrishna D. Early onset Parkinson's disease: are juvenile-and young-onset different? Mov Disord 1994;9:539-544.
29. Golbe LI. Young-onset Parkinson's disease: a clinical review. Neurology 1991;41:168-173.
30. Wiley J, Lynch T, Lincoln S, et al. Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations. Mov Disord 2004;19:677-681.
31. Duvoisin RC, Yahr MD, Lieberman J, Antunes J, Rhee S. The striatal foot. Trans Am Neurol Assoc 1972;267.
32. Ishikawa A, Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 1996;47:160-166. (Pubitemid 26243878)
33. Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson's disease revisited - clinical features, natural history, and mortality. Mov Disord 1998;13:885-894. (Pubitemid 28517664)
34. Van De Warrenburg BP, Lammens M, Lucking CB, et al. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology 2001;56:555-557.
35. Portman AT, Giladi N, Leenders KL, et al. The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations. Neurology 2001;56:1759-1762.
36. Aizawa H, Kwak S, Shimizu T, et al. A case of adult onset pure pallidal degeneration. I. Clinical manifestations and neuropathological observations. J Neurol Sci 1991;102:76-82.
37. Wickremaratchi MM, Majounie E, Morris HR, et al. Parkin-related disease clinically diagnosed as a pallido-pyramidal syndrome. Mov Disord 2009;24:138-140.
38. Fink JK, Filling-Katz MR, Barton NW, Macrae PR, Hallett M, Cohen WE. Treatable dystonia presenting as spastic cerebral palsy. Pediatrics 1988;82:137-138.
39. Boyd K, Patterson V. Dopa responsive dystonia: a treatable condition misdiagnosed as cerebral palsy. BMJ 1989;298:1019-1020. (Pubitemid 19102786)
40. Sakai M, Konagaya M, Kuru S, Kato T, Matsuoka Y, Hashizume Y. Clinico-pathological study of a case of familial parkinsonism with striatal degeneration. Acta Neuropathol 2003;105:76-80. (Pubitemid 36789959)
41. Hanihara T, Inoue K, Kawanishi C, et al. 6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study. Mov Disord 1997;12:408-411.
42. Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood. Pediatrics 2003;111:e89-e97.
43. Schneider SA, Bhatia KP, Hardy J. Complicated recessive dystonia parkinsonism syndromes. Mov Disord 2009;24:490-498.
44. Ramirez A, Heimbach A, Grundemann J, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006;38:1184-1191.
45. Shojaee S, Sina F, Banihosseini SS, et al. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. Am J Hum Genet 2008;82:1375-1384.
46. Di Fonzo A, Dekker MC, Montagna P, et al. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 2009;72:240-245.
47. Di Fonzo A, Chien HF, Socal M, et al. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 2007;68:1557-1562.
48. Najim Al-Din AS, Wriekat A, Mubaidin A, Dasouki M, Hiari M. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol Scand 1994;89: 347-352. (Pubitemid 24163649)
49. Ning YP, Kanai K, Tomiyama H, et al. PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype. Neurology 2008;70:1491-1493.
50. Jellinger K. Degenerations and exogeneous lesions of the pallidum and striatum. In: Vinken P. J., Bruin G. W., Klawans H. L., editors. Extrapyramidal disorders. Amsterdam: Elsevier Science; 1968. p 632-693.
51. Yagishita S, Inoue M. Clinicopathology of spinocerebellar degeneration: its correlation to the unstable CAG repeat of the affected gene. Pathol Int 1997;47:1-15. (Pubitemid 27085899)
52. Jellinger K. Pallidal, pallidonigral and pallidoluysionigral degenerations including association with thalamic and dentate degerations. In: Vinken P. J., Bruin G. W., Klawans H. L., editors. Handbook of clinical neurology, Vol. 49. Amsterdam: Elsevier Science; 1987. p 471-476.
53. Boeve BF, Hutton M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol 2008;65:460-464. (Pubitemid 351549953)
54. Spillantini MG, Van Swieten JC, Goedert M. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics 2000;2:193-205. (Pubitemid 30195998)
55. Wenning GK, Tison F, Ben SY, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147. (Pubitemid 27152018)
56. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994;117: 1183-1196.
57. Yamada H, Momose T, Okada M, Kuroiwa Y. Anticholinergic drugs: response of parkinsonism not responsive to levodopa. J Neurol Neurosurg Psychiatry 2002;72:111-113. (Pubitemid 34073106)
58. Mitsui T, Kawai H, Sakoda S, Miyata M, Saito S. Hereditary parkinsonism with multiple system degeneration: beneficial effect of anticholinergics, but not of levodopa. J Neurol Sci 1994;125: 153-157. (Pubitemid 24275311)
59. Anheim M, Lagier-Tourenne C, Stevanin G, et al. SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J Neurol 2009;256:104-108.
60. Kang SY, Lee MH, Lee SK, Sohn YH. Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum. Parkinsonism Relat Disord 2004;10:425-427. (Pubitemid 39299145)
61. Simon DK, Pulst SM, Sutton JP, Browne SE, Beal MF, Johns DR. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 1999;53:1787-1793. (Pubitemid 29530356)
62. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-870.
63. Geddes JF, Quinn NP, Daniel SE. Juvenile parkinsonism caused by chronic meningoencephalitis: a clinicopathological study. Clin Neuropathol 1993;12:19-24.
64. Lange E, Poppe W, Scholtze P. Familial progressive pallidum atrophy. Eur Neurol 1970;3:265-267.
65. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859-876.
66. Van Bogaert L. Aspects cliniques et pathologiques des atrophies pallidales et pallido-luysiennes progressives. J Neurol Neurosurg Psychiat 1946;9:125-157.
67. Gray F, Eizenbaum JF, Gherardi R, Degos JD, Poirier J. Luysopallido-nigral atrophy and amyotrophic lateral sclerosis. Acta Neuropathol 1985;66:78-82.
68. Mayer JM, Mikol J, Haguenau M, Dellanave J, Pepin B. Familial juvenile parkinsonism with multiple systems degenerations. A clinicopathological study. J Neurol Sci 1986;72:91-101.